Jun 09, 2021 06:17 PM IST
Developed nations like the EU, Australia and Singapore had initially refused to discuss India's revised proposal. The latest decision open the door for larger, more in-depth text based negotiation between all members. Next meeting on 17 June as India pushes for late-July deadline.
- Jun 02, 2021 12:59 PM IST
India’s updated proposal on the global IPR waiver has the support of 62 nations and aims to end the pandemic quickly, but it has been opposed by the European Union, the UK and Australia. It will be next discussed on June 8-9 by the TRIPS council of the WTO.
- May 20, 2021 02:24 PM IST
New Delhi is working with South Africa and other nations to quickly submit by month-end a new, updated draft on its proposal to temporarily suspend parts of the global intellectual property rights agreement. But before it can save lives, the waiver proposal needs to see detailed text-based discussions at the earliest, making it tight deadline
- May 10, 2021 02:31 PM IST
The United States has made it clear that it will not undermine intellectual property regime of the WTO, but will support a waiver for just COVID-19 vaccines
- May 08, 2021 03:14 PM IST
The US has been non-committal about India’s move to get Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver to COVID-19 vaccines at WTO. Now it has decided to offer its support to the proposal.
- May 07, 2021 03:01 PM IST
The US has backed India's proposal to temporarily suspend key clauses of a global intellectual property rights rule to boost vaccine availability. But having introduced it seven months ago, and systematically securing the support from 120 middle- and lower-income nations, New Delhi is now content to let Washington convince the European Union, United Kingdom, Japan, and China.
- May 06, 2021 07:47 AM IST
For the past several weeks, India's Ambassador to the US Taranjit Singh Sandhu, along with the diplomats from South Africa, had been meeting US lawmakers and officials regarding the proposal.
- Apr 26, 2016 10:20 PM IST
India today said its intellectual property rights regime is fully in compliance with global norms and the country will not succumb to "any pressure from any where" to modify it.
- Aug 16, 2012 09:41 PM IST
By granting compulsory license to Natco for Bayer's kidney cancer drug Nexavar, the Indian government has opened a legal can of worms, reports CNBC-TV18's Archana Shukla.
- Jul 07, 2011 07:29 PM IST
India has promised not to link a proposed trade deal with the European Union with limiting its production of generic HIV/AIDS drugs, the United Nations said on Thursday, giving hope to millions of infected patients but underlining the hurdles for the controversial pact.